Viewing Study NCT06613295


Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2026-04-26 @ 3:51 PM
Study NCT ID: NCT06613295
Status: RECRUITING
Last Update Posted: 2024-09-25
First Post: 2024-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
Sponsor: Cancer Research Antwerp
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CTO21003GZA
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators